Capastat Sulfate

Product manufactured by Akorn

Application Nr Approved Date Route Status External Links
NDA050095 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Capastat Sulfate, Which Is To Be Used Concomitantly With Other Appropriate Antituberculosis Agents, Is Indicated In Pulmonary Infections Caused By Capreomycin-Susceptible Strains Of M. Tuberculosis When The Primary Agents (Isoniazid, Rifampin, Ethambutol, Aminosalicylic Acid, And Streptomycin) Have Been Ineffective Or Cannot Be Used Because Of Toxicity Or The Presence Of Resistant Tubercle Bacilli. Susceptibility Studies Should Be Performed To Determine The Presence Of A Capreomycin-Susceptible Strain Of M. Tuberculosis .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Capreomycin Sulfate CAPREOMYCIN SULFATE ZINC49592787

Comments